Does adherence to disease modifying agents influence quality of life in patients with multiple sclerosis?

被引：0
|
作者：
Cerghet, Mirela
Elston-Lafata, Jennifer
Schultz, Lonni
Elias, Stanton
Dobie, Elizabeth
Tunceli, Kaan
Reuther, Jackqueline
机构：
来源：
NEUROLOGY | 2008年 / 70卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A271 / A271
页数：1
相关论文
共 50 条
  • [1] ADHERENCE OF MULTIPLE SCLEROSIS PATIENTS TO DISEASE MODIFYING TREATMENT AND ITS IMPACT ON QUALITY OF LIFE
    de Scheffer, Apecechea M.
    Faber, S.
    Potthoff, P.
    Eichmann, F.
    VALUE IN HEALTH, 2014, 17 (03) : A62 - A62
  • [2] Quality of life for veterans with multiple sclerosis on disease-modifying agents: Relationship to disability
    Guarnaccia, Joseph B.
    Aslan, Mihaela
    O'Connor, Theresa Z.
    Hope, MaryAnn
    Kazis, Lewis
    Kashner, C. Michael
    Booss, John
    JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT, 2006, 43 (01): : 35 - 44
  • [3] Racial disparities in adherence to disease-modifying agents and quality of life in patients with MS
    Cerghet, Mirela
    Schultz, Lonni
    Dobie, Elizabeth
    Reuther, Jacqueline
    Elias, Stanton
    Lafata, Jennifer Elston
    MULTIPLE SCLEROSIS, 2008, 14 : S139 - S139
  • [4] Adherence to disease-modifying therapies in patients with multiple sclerosis
    Koltuniuk, Aleksandra
    Rosinczuk, Joanna
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1557 - 1565
  • [5] Factors that influence adherence with disease-modifying therapy in multiple sclerosis
    Treadaway, K
    Hawker, K
    Racke, M
    Brannon, K
    Morrison, A
    Remington, G
    Frohman, E
    Cohen, B
    Corboy, J
    Simsarian, J
    Lynch, S
    Jeffery, D
    MULTIPLE SCLEROSIS, 2005, 11 : S158 - S158
  • [6] Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis
    Earla, Jagadeswara Rao
    Li, Jieni
    Hutton, George J.
    Johnson, Michael L.
    Aparasu, Rajender R.
    PHARMACOTHERAPY, 2023, 43 (06): : 473 - 484
  • [7] Factors that influence adherence with disease-modifying therapy in multiple sclerosis
    Treadaway, KD
    Brannon, KD
    Morrison, A
    Remington, GM
    Olek, M
    Racke, MK
    Frohman, EM
    NEUROLOGY, 2006, 66 (05) : A30 - A30
  • [8] Adherence to Disease-Modifying Agents among Patients with Multiple Sclerosis: 5 Year Prospective Study
    Cerghet, Mirela
    Elias, Stanton
    Dobie, Liz
    Salloum, Ramzi
    Elston-Lafata, Jennifer
    Schultz, Lonni
    NEUROLOGY, 2011, 76 (09) : A72 - A73
  • [9] Measuring adherence and persistence to disease-modifying agents among patients with relapsing remitting multiple sclerosis
    Lafata, Jennifer Elston
    Cerghet, Mirela
    Dobie, Elizabeth
    Schultz, Lonni
    Tunceli, Kaan
    Reuther, Jacqueline
    Elias, Stanton
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2008, 48 (06) : 752 - 757
  • [10] Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain
    Morillo Verdugo, Ramon
    Ramirez Herraiz, Esther
    Fernandez-Del Olmo, Raquel
    Roig Bonet, Montserrat
    Valdivia Garcia, Maria
    PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 261 - 272
12345